Wikipedia:WikiProject Chemicals/Chembox validation/VerifiedDataSandbox and Indigo carmine: Difference between pages
Appearance
(Difference between pages)
Content deleted Content added
Saving copy of the {{chembox}} taken from revid 472376837 of page Indigo_carmine for the Chem/Drugbox validation project (updated: ''). |
einecs |
||
Line 1: | Line 1: | ||
{{Short description|Blue dye derived from indigo}} |
|||
{{ambox | text = This page contains a copy of the infobox ({{tl|chembox}}) taken from revid [{{fullurl:Indigo_carmine|oldid=472376837}} 472376837] of page [[Indigo_carmine]] with values updated to verified values.}} |
|||
{{About|the blue dye derived from indigo|the unrelated red dye|Carmine||Carmine (disambiguation)}} |
|||
{{cs1 config|name-list-style=vanc|display-authors=6}} |
|||
{{chembox |
{{chembox |
||
| Verifiedfields = changed |
|||
| verifiedrevid = 445994584 |
|||
| Watchedfields = changed |
|||
| verifiedrevid = 477001402 |
|||
| ImageFile = Indigo carmine.svg |
| ImageFile = Indigo carmine.svg |
||
| ImageSize = 300px |
| ImageSize = 300px |
||
| ImageFile1 = |
| ImageFile1 =Indigo-carmine-3D-balls.png |
||
| ImageSize1 = |
| ImageSize1 =300px |
||
| PIN = Disodium [2(2′)''E'']-3,3′-dioxo-1,1′,3,3′-tetrahydro[2,2′-biindolylidene]-5,5′-disulfonate |
|||
| IUPACName = 3,3'-dioxo-2,2'-bis-indolyden-5,5'-disulfonic acid disodium salt |
|||
| OtherNames = |
| OtherNames = {{Unbulleted list|indigotine|5,5′-indigodisulfonic acid sodium salt|Brilliant Indigo|4 G|C.I. Acid Blue 74|C.I. 73015|CI Food Blue 1|FD&C Blue 2|Sicovit Indigotin 85|E132|indigotindisulfonate sodium}} |
||
| |
|Section1={{Chembox Identifiers |
||
| Identifiers_ref = |
|||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|||
<!-- indexlabeling--> |
|||
| index_label = |
|||
| index1_label = |
|||
| indexlist_caption = |
|||
| index_comment = |
|||
| index1_comment = |
|||
<!--CASNo, +ix 1–5--> |
|||
| CASNo_Ref = {{cascite|correct|CAS}} |
|||
| CASNo = 860-22-0 |
|||
| CASNo_Comment = |
|||
<!--ChEBI, +ix 1–5--> |
|||
| ChEBI_Ref = {{ebicite|changed|EBI}} |
|||
| ChEBI = 31695 |
|||
| ChEBI_Comment = |
|||
<!--ChEMBL, +ix 1–5--> |
|||
| ChEMBL = 2105023 |
|||
| ChEMBL_Comment = |
|||
<!--ChemSpiderID, +ix 1–5--> |
|||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|||
| ChemSpiderID = 4447431 |
| ChemSpiderID = 4447431 |
||
| ChemSpiderID_Comment = |
|||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
<!--DrugBank, +ix 1–5--> |
|||
| UNII = D3741U8K7L |
|||
| DrugBank = DB11577 |
|||
| InChI = 1/C16H10N2O8S2.2Na/c19-15-9-5-7(27(21,22)23)1-3-11(9)17-13(15)14-16(20)10-6-8(28(24,25)26)2-4-12(10)18-14;;/h1-6,17-18H,(H,21,22,23)(H,24,25,26);;/q;2*+1/p-2/b14-13+;; |
|||
| DrugBank_Comment = |
|||
| InChIKey = KHLVKKOJDHCJMG-AKPRSONXBD |
|||
| DrugBank1 = DBSALT001752 |
|||
| DrugBank1_Comment = |
|||
| EC_number = 212-728-8 |
|||
<!--IUPHAR_ligand, +ix 1–5--> |
|||
| IUPHAR_ligand = |
|||
| IUPHAR_ligand_Comment = |
|||
<!--KEGG, +ix 1–5--> |
|||
| KEGG = D01563 |
|||
| KEGG_Comment = |
|||
<!--PubChem, +ix 1–5--> |
|||
| PubChem = 2723854 |
|||
| PubChem_Comment = |
|||
<!--SMILES, Jmol 1–5--> |
|||
| SMILES = [Na+].[Na+].[O-]S(=O)(=O)c3cc4C(=O)\C(=C2\C(=O)c1cc(ccc1N2)S([O-])(=O)=O)Nc4cc3 |
|||
| SMILES_Comment = |
|||
<!--StdInChI--> |
|||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChI = 1S/C16H10N2O8S2.2Na/c19-15-9-5-7(27(21,22)23)1-3-11(9)17-13(15)14-16(20)10-6-8(28(24,25)26)2-4-12(10)18-14;;/h1-6,17-18H,(H,21,22,23)(H,24,25,26);;/q;2*+1/p-2/b14-13+;; |
| StdInChI = 1S/C16H10N2O8S2.2Na/c19-15-9-5-7(27(21,22)23)1-3-11(9)17-13(15)14-16(20)10-6-8(28(24,25)26)2-4-12(10)18-14;;/h1-6,17-18H,(H,21,22,23)(H,24,25,26);;/q;2*+1/p-2/b14-13+;; |
||
| StdInChI_Comment = |
|||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChIKey = KHLVKKOJDHCJMG-QDBORUFSSA-L |
| StdInChIKey = KHLVKKOJDHCJMG-QDBORUFSSA-L |
||
<!--InChI, InChIKey: index 1–5--> |
|||
| CASNo_Ref = {{cascite|correct|CAS}} |
|||
| InChI = 1/C16H10N2O8S2.2Na/c19-15-9-5-7(27(21,22)23)1-3-11(9)17-13(15)14-16(20)10-6-8(28(24,25)26)2-4-12(10)18-14;;/h1-6,17-18H,(H,21,22,23)(H,24,25,26);;/q;2*+1/p-2/b14-13+;; |
|||
| CASNo = 860-22-0 |
|||
| InChI_Comment = |
|||
| PubChem = 5284351 |
|||
| InChIKey = KHLVKKOJDHCJMG-AKPRSONXBD |
|||
<!--UNII, +ix 1–5--> |
|||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
| UNII = D3741U8K7L |
|||
| UNII_Comment = |
|||
<!--non-index parameters--> |
|||
| Abbreviations = |
|||
| Beilstein = |
|||
| Gmelin = |
|||
| MeSHName = |
|||
| UNNumber = |
|||
}} |
|||
|Section2={{Chembox Properties |
|||
| Formula = C<sub>16</sub>H<sub>8</sub>N<sub>2</sub>Na<sub>2</sub>O<sub>8</sub>S<sub>2</sub> |
|||
| MolarMass = 466.36 g/mol |
|||
| Appearance = purple solid |
|||
| Density = |
|||
| MeltingPt = >{{convert|300|C}} |
|||
| BoilingPt = |
|||
| Solubility = 10 g/L ({{convert|25|C}}) |
|||
}} |
|||
|Section3={{Chembox Hazards |
|||
| GHSPictograms = {{GHS exclamation mark}}<ref name=sigma>{{cite web|title=Indigo carmine|url=http://www.sigmaaldrich.com/MSDS/MSDS/DisplayMSDSPage.do?country=TH&language=en&productNumber=131164&brand=SIAL&PageToGoToURL=http%3A%2F%2Fwww.sigmaaldrich.com%2Fcatalog%2Fproduct%2Fsial%2F131164%3Flang%3Den|website=Sigma Aldrich|access-date=15 Feb 2022}}</ref> |
|||
| GHSSignalWord = '''Warning''' |
|||
| HPhrases = {{H-phrases|302}}<ref name=sigma /> |
|||
| PPhrases = |
|||
| MainHazards = |
|||
| FlashPt = |
|||
| AutoignitionPt = |
|||
| NFPA-H = 2 |
|||
| NFPA-F = 1 |
|||
| NFPA-R = 0 |
|||
| NFPA-S = |
|||
}} |
|||
| Section6 = {{Chembox Pharmacology |
|||
| Pharmacology_ref = |
|||
| ATCCode_prefix = V04 |
| ATCCode_prefix = V04 |
||
| ATCCode_suffix = CH02 |
| ATCCode_suffix = CH02 |
||
| ATC_Supplemental = |
|||
| SMILES = [Na+].[Na+].[O-]S(=O)(=O)c3cc4C(=O)\C(=C2\C(=O)c1cc(ccc1N2)S([O-])(=O)=O)Nc4cc3 |
|||
| ATCvet = |
|||
}} |
|||
| Licence_EU = |
|||
| Section2 = {{Chembox Properties |
|||
| INN = |
|||
| Formula = C<sub>16</sub>H<sub>8</sub>N<sub>2</sub>Na<sub>2</sub>O<sub>8</sub>S<sub>2</sub> |
|||
| |
| INN_EMA = |
||
| Licence_US = |
|||
| Appearance = purple solid |
|||
| Legal_status = |
|||
| Density = |
|||
| |
| Legal_AU = |
||
| Legal_AU_comment = |
|||
| BoilingPt = |
|||
| Legal_CA = |
|||
| Solubility = 10 g/L (25 °C) |
|||
| Legal_CA_comment = |
|||
}} |
|||
| Legal_NZ = |
|||
| Section3 = {{Chembox Hazards |
|||
| Legal_NZ_comment = |
|||
| MainHazards = |
|||
| Legal_UK = |
|||
| FlashPt = |
|||
| Legal_UK_comment = |
|||
| Autoignition = |
|||
| Legal_US = Rx-only |
|||
| Legal_US_comment = <ref name="Bludigo FDA label">{{cite web | title=Bludigo- indigotindisulfonate sodium injection | website=DailyMed | date=7 November 2022 | url=https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=73f246c4-b127-452e-856f-134b56cb8870 | access-date=21 January 2023}}</ref> |
|||
| Legal_EU = |
|||
| Legal_EU_comment = |
|||
| Legal_UN = |
|||
| Legal_UN_comment = |
|||
| Pregnancy_category = |
|||
| Pregnancy_AU = |
|||
| Pregnancy_AU_comment = |
|||
| Dependence_liability = |
|||
| AdminRoutes = |
|||
| Bioavail = |
|||
| ProteinBound = |
|||
| Metabolism = |
|||
| Metabolites = |
|||
| OnsetOfAction = |
|||
| HalfLife = |
|||
| DurationOfAction = |
|||
| Excretion = |
|||
}} |
}} |
||
|Section7={{Chembox Hazards |
|||
| MainHazards = |
|||
| FlashPt = |
|||
| AutoignitionPt = |
|||
}} |
|||
}} |
|||
{{Infobox drug |
|||
| drug_name = Indigotindisulfonate sodium |
|||
| INN = |
|||
| type = <!-- empty --> |
|||
| image = |
|||
| width = |
|||
| alt = |
|||
| caption = |
|||
<!-- Clinical data --> |
|||
| pronounce = |
|||
| tradename = Bludigo |
|||
| Drugs.com = |
|||
| MedlinePlus = |
|||
| licence_CA = <!-- Health Canada may use generic or brand name (generic name preferred) --> |
|||
| licence_EU = <!-- EMA uses INN (or special INN_EMA) --> |
|||
| DailyMedID = Indigotindisulfonate |
|||
| licence_US = <!-- FDA may use generic or brand name (generic name preferred) --> |
|||
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
|||
| pregnancy_AU_comment = |
|||
| pregnancy_category = |
|||
| routes_of_administration = |
|||
| class = |
|||
| ATCvet = |
|||
| ATC_prefix = |
|||
| ATC_suffix = |
|||
| ATC_supplemental = |
|||
<!-- Legal status --> |
|||
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled --> |
|||
| legal_AU_comment = |
|||
| legal_BR = <!-- OTC, A1, A2, A3, B1, B2, C1, C2, C3, C4, C5, D1, D2, E, F --> |
|||
| legal_BR_comment = |
|||
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII --> |
|||
| legal_CA_comment = |
|||
| legal_DE = <!-- Anlage I, II, III or Unscheduled --> |
|||
| legal_DE_comment = |
|||
| legal_NZ = <!-- Class A, B, C --> |
|||
| legal_NZ_comment = |
|||
| legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM / Class A, B, C --> |
|||
| legal_UK_comment = |
|||
| legal_US = |
|||
| legal_US_comment = |
|||
| legal_EU = |
|||
| legal_EU_comment = |
|||
| legal_UN = <!-- N I, II, III, IV / P I, II, III, IV --> |
|||
| legal_UN_comment = |
|||
| legal_status = <!-- For countries not listed above --> |
|||
<!-- Pharmacokinetic data --> |
|||
| bioavailability = |
|||
| protein_bound = |
|||
| metabolism = |
|||
| metabolites = |
|||
| onset = |
|||
| elimination_half-life = |
|||
| duration_of_action = |
|||
| excretion = |
|||
<!-- Identifiers --> |
|||
| CAS_number = |
|||
| CAS_supplemental = |
|||
| PubChem = |
|||
| IUPHAR_ligand = |
|||
| DrugBank = |
|||
| ChemSpiderID = |
|||
| UNII = |
|||
| KEGG = |
|||
| ChEBI = |
|||
| ChEMBL = |
|||
| NIAID_ChemDB = |
|||
| PDB_ligand = |
|||
| synonyms = |
|||
<!-- Chemical and physical data --> |
|||
| IUPAC_name = |
|||
| chemical_formula_ref = |
|||
| chemical_formula = |
|||
| C= | H= | Ag= | Al= | As= | Au= | B= | Bi= | Br= | Ca= | Cl= | Co= | F= | Fe= | Gd= | I= |
|||
| K= | Li= | Mg= | Mn= | N= | Na= | O= | P= | Pt= | S= | Sb= | Se= | Sr= | Tc= | Zn= | charge= |
|||
| molecular_weight = |
|||
| molecular_weight_comment = |
|||
| SMILES = |
|||
| StdInChI = |
|||
| StdInChI_comment = |
|||
| StdInChIKey = |
|||
| density = |
|||
| density_notes = |
|||
| melting_point = |
|||
| melting_high = |
|||
| melting_notes = |
|||
| boiling_point = |
|||
| boiling_notes = |
|||
| solubility = |
|||
| sol_units = |
|||
| specific_rotation = |
|||
}} |
}} |
||
'''Indigo carmine''', or '''5,5′-indigodisulfonic acid sodium salt''', is an [[wikt:organic salt#English|organic salt]] derived from [[Indigo dye|indigo]] by [[aromatic sulfonation]], which renders the compound soluble in water. Like indigo, it [[Blue#Colourants|produces a blue color]], and is used in [[food colorant|food and other consumables]], cosmetics, and as a medical [[contrast agent]] and [[staining]] agent; it also acts as a [[pH indicator]]. It is approved for human consumption in the United States and European Union.<ref name="FDA colors">[https://www.fda.gov/ForIndustry/ColorAdditives/ColorAdditiveInventories/ucm115641.htm Summary of Color Additives for Use in United States in Foods, Drugs, Cosmetics, and Medical Devices], [[Food and Drug Administration]]</ref><ref name=FSAlist>[http://www.food.gov.uk/safereating/chemsafe/additivesbranch/enumberlist Current EU approved additives and their E Numbers], [[Food Standards Agency]], 26 November 2010</ref> It has the [[E number]] '''E132''', and is named '''Blue No. 2''' by the US [[Federal Food, Drug, and Cosmetic Act]]. |
|||
==Uses== |
|||
{{pH_indicator_template|indicator_name=Indigo Carmine|low_pH=11.4|high_pH=13.0|low_pH_color=blue|low_pH_text=white|high_pH_color=yellow}} |
|||
[[File:Индигокармин.jpg|thumb|Experiment using indigo carmine as an indicator]] |
|||
Indigo carmine in a 0.2% [[aqueous solution]] is blue at [[pH]] 11.4 and yellow at 13.0. Indigo carmine is also a [[redox indicator]], turning yellow upon reduction. Another use is as a dissolved [[ozone]] indicator<ref name="pmid2729594">{{cite journal | vauthors = Takeuchi K, Ibusuki T | title = Quantitative determination of aqueous-phase ozone by chemiluminescence using indigo-5,5'-disulfonate | journal = Analytical Chemistry | volume = 61 | issue = 6 | pages = 619–623 | date = March 1989 | pmid = 2729594 | doi = 10.1021/ac00181a025 }}</ref> through the conversion to isatin-5-sulfonic acid.<ref name="pmid2729594" /> This reaction has been shown not to be specific to ozone: it also detects [[superoxide]], an important distinction in cell physiology.<ref name="pmid14978029">{{cite journal | vauthors = Kettle AJ, Clark BM, Winterbourn CC | title = Superoxide converts indigo carmine to isatin sulfonic acid: implications for the hypothesis that neutrophils produce ozone | journal = The Journal of Biological Chemistry | volume = 279 | issue = 18 | pages = 18521–18525 | date = April 2004 | pmid = 14978029 | doi = 10.1074/jbc.M400334200 | doi-access = free }}</ref> It is also used as a dye in the manufacturing of [[Capsule (pharmacy)|capsules]]. |
|||
=== Medical uses === |
|||
[[File:Indigo carmine.jpg|thumb|Container of indigotindisulfonate sodium for medical use.]] |
|||
'''Indigotindisulfonate sodium''', sold under the brand name '''Bludigo''', is used as a [[contrast agent]] during surgical procedures.<ref name="Bludigo FDA label" /> It is [[indicated]] for use in [[cystoscopy]] in adults following [[urological]] and [[gynecological]] procedures.<ref name="Bludigo FDA label" /><ref name="FDA approval letter">{{cite web | title = NDA APPROVAL: Bludigo (indigotindisulfonate sodium) injection | url = https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/216264Orig1s000ltr.pdf | publisher = U.S. Food and Drug Administration }} {{PD-notice}}</ref> It was approved for medical use in the United States in July 2022.{{specify|Presumably means only this particular product?|date=August 2024}}<ref name="Bludigo FDA label" /><ref name="FDA approval letter" /> |
|||
In [[obstetric surgery]], it may be used to detect [[amniotic fluid]] leaks. In urologic surgery, intravenous indigo carmine can be used to highlight portions of the [[urinary tract]]. The dye is filtered rapidly by the kidneys from the blood, and colors the urine blue. However, the dye can cause a potentially dangerous acute increase in [[blood pressure]] in some cases.<ref>{{cite journal | vauthors = Craik JD, Khan D, Afifi R |title=The Safety of Intravenous Indigo Carmine to Assess Ureteric Patency During Transvaginal Uterosacral Suspension of the Vaginal Vault |journal=Journal of Pelvic Medicine & Surgery |date=January–February 2009 |volume=15 |issue=1 |pages=11–15 |doi=10.1097/SPV.0b013e3181986ace }}</ref> |
|||
Indigo carmine [[staining|stain]] is not absorbed into cells, so it is applied to tissues to enhance the visibility of [[mucosa]]. This leads to its use for examination and diagnosis of [[benign tumor|benign]] and [[malignant]] lesions and growths on mucosal surfaces of the body.<ref>{{cite journal | vauthors = Jang JY | title = The Past, Present, and Future of Image-Enhanced Endoscopy | journal = Clinical Endoscopy | volume = 48 | issue = 6 | pages = 466–475 | date = November 2015 | pmid = 26668791 | pmc = 4676674 | doi = 10.5946/ce.2015.48.6.466 | doi-access = free }}</ref> |
|||
=== Food, pharmaceutical, cosmetic, and scientific uses === |
|||
Indigo carmine is one of the few blue food colorants. Others include the [[anthocyanidins]] and rare entites such as [[variagatic acid]] and [[popolohuanone]].<ref>{{cite journal | vauthors = Newsome AG, Culver CA, van Breemen RB | title = Nature's palette: the search for natural blue colorants | journal = Journal of Agricultural and Food Chemistry | volume = 62 | issue = 28 | pages = 6498–6511 | date = July 2014 | pmid = 24930897 | doi = 10.1021/jf501419q }}</ref> |
|||
==Safety and regulation== |
|||
{{Missing information|article|legal status outside US/EU and most usages|date=August 2024}} |
|||
Indigo carmin shows "genotoxicity, developmental toxicity or modifications of haematological parameters in chronic toxicity studies". Only at 17 mg/kg of body weight per day were effects on testes observed.<ref>{{cite journal | vauthors = Amchova P, Kotolova H, Ruda-Kucerova J | title = Health safety issues of synthetic food colorants | journal = Regulatory Toxicology and Pharmacology | volume = 73 | issue = 3 | pages = 914–922 | date = December 2015 | pmid = 26404013 | doi = 10.1016/j.yrtph.2015.09.026 }}</ref> |
|||
== References == |
|||
{{reflist}} |
|||
== External links == |
|||
{{Diagnostic agents}} |
|||
{{Portal bar | Medicine}} |
|||
{{DEFAULTSORT:Indigo Carmine}} |
|||
[[Category:PH indicators]] |
|||
[[Category:Sulfonates]] |
|||
[[Category:Organic sodium salts]] |
|||
[[Category:Indoles]] |
|||
[[Category:Enones]] |
|||
[[Category:Food colorings]] |
|||
[[Category:Redox indicators]] |
|||
[[Category:E-number additives]] |
|||
[[Category:Acid dyes]] |